Shopping on line can be easy, simple and save you lots of money. It can also take a lot of your time, frustrate you, and result in unwanted purchases. Now the same can be said for regular high street shopping, but with the vast opportunity presented by the Internet it will pay you to spend a few minutes reading this and understanding how to better optimize your Diabetes Mellitus Type 2 shopping experience:

1. Compare - without doubt the biggest advantage that the Diabetes Mellitus Type 2 offers shoppers today is the ability to compare thousands of Diabetes Mellitus Type 2 at a time. This is a great thing, but not necessarily all the time! Too much can be daunting at times so take advantage of the great comparison sites and where possible let them do the hard work for you.

2. Research - if it has been said it will be on the internet. Ignorance is no longer a justifiable reason for buying the wrong thing. Take the time to research in detail everything that you could possible want to know about

3. Testimonials - don't know anybody that has bought a Diabetes Mellitus Type 2? Wrong! If the Diabetes Mellitus Type 2 is good the internet will let you know. Use the Internet as a friend and get testimonials before you buy.

4. Questions - Got a question about Diabetes Mellitus Type 2 then search the Forums, FAQ's, Blogs etc. Don't be afraid to ask .....

5. Reputation - Never heard of the company selling Diabetes Mellitus Type 2? Don't worry, no reason why you should know every company in the world, but you know someone that does! Use the internet to find out what people are saying about Diabetes Mellitus Type 2 and build up a picture of their reputation for sales, returns, customer service, delivery etc.

6. Returns - still worried that even after all of the above your Diabetes Mellitus Type 2 wont be what you want? Check out the returns policy. There is so much competition now that someone, somewhere is bound to offer the terms that you are comfortable with.

7. Feedback - happy with your Diabetes Mellitus Type 2 then let people know, after all you are depending on others people input in your buying decision, so why not give a little back.

8. Security - check for the yellow padlock on the Diabetes Mellitus Type 2 site before you buy, and the s after http:/ /i.e. https:// = a secure site

9. Contact - got a question about Diabetes Mellitus Type 2, or want to leave a comment then check out the sites contact page. Reputable companies have them and respond.

10. Payment - ready to pay for your Diabetes Mellitus Type 2, then use your credit card or PayPal! Be aware of companies that don't accept them, there may be genuine reasons but given the huge amount of choice you have when buying online there is no reason at all not to buy via credit card or PayPal.

Diabetes mellitus type 2 (formerly called diabetes mellitus type II, non insulin-dependent diabetes (NIDDM), obesity related diabetes, or adult-onset diabetes) is a metabolism disorder that is primarily characterized by insulin resistance, relative insulin deficiency, and hyperglycemia. It is often managed by engaging in exercise and modifying one's diet. It is rapidly increasing in the developed world, and there is some evidence that this pattern will be followed in much of the rest of the world in coming years. The Centers for Disease Control and Prevention has characterized the increase as an epidemic.{{Citation | last =Gerberding | first =Julie Louise | title =Diabetes, Disabling Disease to Double by 2050 | date =2007-05-24 | year =2007 | publisher =CDC | url =http://www.cdc.gov/nccdphp/publications/aag/ddt.htm | accessdate =2007-09-14 -->

Unlike Diabetes mellitus type 1 diabetes, there is little tendency toward ketoacidosis in Type 2 diabetes, though it is not unknown. One effect that can occur is Non Ketonic Hyperglycemic coma. Complex and multifactorial metabolic changes lead to damage and function impairment of many organ (anatomy)s, most importantly the cardiovascular system in both types. This leads to substantially increased morbidity and death in both Type 1 and Type 2 patients, but the two have quite different origins and treatments despite the similarity in complications.
Pathophysiology Insulin resistance means that body cell (biology) do not respond appropriately when insulin is present.

Other important contributing factors:

This is a more complex problem than type 1, but is sometimes easier to treat, especially in the initial years when insulin is often still being produced internally. Type 2 may go unnoticed for years in a patient before diagnosis, since the symptoms are typically milder (no ketoacidosis) and can be sporadic. However, severe complications can result from unnoticed type 2 diabetes, including renal failure, blindness, wounds that fail to heal, and coronary artery disease. The onset of the disease is most common in middle age and old age.

Diabetes mellitus type 2 is as of 2006 of unknown etiology (i.e., origin). Diabetes mellitus with a known etiology, such as secondary to other diseases, known gene defects, trauma or surgery, or the effects of drugs, is more appropriately called secondary diabetes mellitus. Examples include diabetes mellitus caused by hemochromatosis, pancreatic insufficiency, or certain types of medications (e.g. long-term steroid use).

About 90–95% of all North American cases of diabetes are type 2Zimmet, P., Alberti, K. G. M. M., Shaw, J. Global and societal implications of thediabetes epidemic. Nature 2001, 414, 782-787., and about 20% of the population over the age of 65 has diabetes mellitus type 2. The fraction of type 2 diabetics in other parts of the world varies substantially, almost certainly for environmental and lifestyle reasons, though these are not known in detail. Diabetes affects over 150 million people worldwide with this number expected to double by 2025. There is also a strong inheritable genetics connection in type 2 diabetes: having relatives (especially first degree) with type 2 is a considerable risk factor for developing type 2 diabetes. In addition there is also a mutation to the Islet Amyloid Polypeptide gene that results in an earlier onset, more severe form of diabetesSakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y.,Nakajima, K. & Nanjo, K. Missense mutation of amylin gene (S20G) in Japanese NIDDMpatients. Diabetes 1996, 45, 1279-1281.,Seino, S. S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Diabetologia 2001, 44, (7), 906-909.. About 55 percent of type 2 are obesity —chronic obesity leads to increased insulin resistance that can develop into diabetes, most likely because adipose tissue is a (recently identified) source of chemical signals (hormones and cytokines). Other research shows that type 2 diabetes causes obesity.

Diabetes mellitus type 2 is often associated with obesity and hypertension and elevated cholesterol (combined hyperlipidemia), and with the condition Metabolic syndrome (also known as Syndrome X, Reavan's syndrome, or CHAOS). It is also associated with acromegaly, Cushing's syndrome and a number of otherendocrinology disorders. Additional factors found to increase risk of type 2 diabetes include agingJack, L., Jr., Boseman, L. & Vinicor, F. Aging Americans and diabetes. A public health and clinical response. Geriatrics 2004, 59, 14-17., high-fat dietsLovejoy, J. C. The influence of dietary fat on insulin resistance. Curr Diab Rep 2002, 2,435-440. and a less active lifestyleHu, F. B. Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 2003, 38,103-108..

Diagnosis The World Health Organization definition of diabetes is for a single raised glucose reading with symptoms, otherwise raised values on two occasions, of either.: or

Screening and prevention Interest has arisen in preventing diabetes due to research on the benefits of treating patients before overt diabetes. Although the U.S. Preventive Services Task Force (USPSTF) concluded that "the evidence is insufficient to recommend for or against routinely screening asymptomatic adults for type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose" National Guidelines Clearinghouse: Complete Summary, this was a grade I recommendation when published in 2003. However, the USPSTF does recommend screening for diabetics in adults with hypertension or hyperlipidemia ( grade B recommendation).

In 2005, an evidence report by the Agency for Healthcare Research and Quality concluded that "there is evidence that combined diet and exercise, as well as drug therapy (metformin, acarbose), may be effective at preventing progression to DM in IGT subjects".

Accuracy of tests for early detection If a 2-hour postload glucose level of at least 11.1 mmol/L (≥ 200 mg/dL) is used as the reference standard, the fasting plasma glucose > 7.0 mmol/L (126 mg/dL) diagnoses current diabetes with:

A random capillary blood glucose > 6.7 mmol/L (120 mg/dL) diagnoses current diabetes with:

Glycosylated hemoglobin values that are elevated (over 5%), but not in the diabetic range (not over 7.0%) are predictive of subsequent clinical diabetes in US female health professionals. In this study, 177 of 1061 patients with glycosylated hemoglobin value less than 6% became diabetic within 5 years compared to 282 of 26281 patients with a glycosylated hemoglobin value of 6.0% or more. This equates to a glycosylated hemoglobin value of 6.0% or more having:

Benefit of early detection Since publication of the USPSTF statement, a randomized controlled trial of prescribing acarbose to patients with "high-risk population of men and women between the ages of 40 and 70 years with a body mass index (BMI), calculated as weight in kilograms divided by the square of height in meters, between 25 and 40. They were eligible for the study if they had Impaired glucose tolerance according to the World Health Organization criteria, plus impaired fasting glucose (a fasting plasma glucose concentration of between 100 and 140 mg/dL or 5.5 and 7.8 mmol/L) found a number needed to treat of 44 (over 3.3 years) to prevent a major cardiovascular event ACP Journal Club review.

Other studies have shown that life-style changes ACP Journal Club review and metformin ACP Journal Club review can delay the onset of diabetes.

Treatment Diabetes mellitus type 2 is a chronic, progressive disease that has no medically proven cure. There are two main goals of treatment of the disease:
  • reduction of mortality and concomitant morbidity (from assorted diabetic complications)
  • preservation of quality of life
    • The first goal can be achieved through close glycemic control (i.e., blood glucose levels); the reduction effect in diabetic complications has been well demonstrated in several extensive clinical trials and is thus well established. The second goal is often addressed (in developed countries) by support and care from teams of diabetic health workers (physician, PA, nurse, dietitian or a certified diabetic educator). Endocrinologists, family practitioners, and general internists are the types of physicians most likely to treat people with diabetes. Knowledgeable patient participation is vital and so patient education is a crucial aspect of this effort.

    Type 2 is initially treated by adjustment in diet and exercise, and by weight loss, especially in obese patients. The amount of weight loss which improves the clinical picture is sometimes modest (2-5 kg or 4.4-11 lb); this is almost certainly due to currently poorly understood aspects of fat tissue chemical signaling (especially in visceral fat tissue in and around abdominal organs). In many cases, such initial efforts can substantially restore insulin sensitivity.

    Treatment goals For most patients, clinical practice guidelines recommend a goal Glycosylated hemoglobin of 6.0% to 7.0%Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK, et al. Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1c Targets. A Guidance Statement from the American College of Physicians. Ann Intern Med. 2007 Sep 18;147(6):417-422. Full text.

    In older patients, clinical practice guidelines by the American Geriatrics Society states "for frail older adults, persons with life expectancy of less than 5 years, and others in whom the risks of intensive glycemic control appear to outweigh the benefits, a less stringent target such as 8% is appropriate".

    Self monitoring of blood glucose It is unclear if self-monitoring of blood glucose improves outcomes among "reasonably well controlled non-insulin treated patients with type 2 diabetes".

    Dietary management Modifying the diet is known to help control glucose intake, and in response, blood glucose levels.

    One 2007 study will report that in a Paleolithic diet, all 14 patients returned blood glucose levels to normal after the trial period of 12 weeks, and improved glucose tolerance (26% less blood glucose rise following a carbohydrate intake compared to 7% reduction for control group on a Mediterranean diet). This was the first Paleolithic diet study, and suggested that "it may be more efficient to avoid some of our modern foods than to count calories or carbohydrate".

    Other evidence for modified diets treating and being beneficial include:

    Exercise In September 2007, a joint randomized controlled trial by the University of Calgary and the University of Ottawa found that "Either aerobic or resistance training alone improves glycemic control in type 2 diabetes, but the improvements are greatest with combined aerobic and resistance training than either alone." Non-technical summary{{cite web ] by 0.5 percentage point.

    Antidiabetic drugs The most important drug now used in Type 2 Diabetes is the Biguanide metformin which works primarily by reducing liver release of blood glucose from glycogen stores as well as some increase in uptake of glucose by the body's tissues. Both historically and currently commonly used are the Sulfonylurea group, of which several members (including glibenclamide and gliclazide) are widely used; these increase glucose stimulated secretagogue by the pancreas.

    Newer drug classes include:

    Selecting an antidiabetic drug Oral drugs A systematic review of randomized controlled trials found that metformin and second-generation sulfonylureas are the preferred choices for most.Bolen S et al. Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus. Ann Intern Med 2007;147:6 Failure of response after a time is not unknown with most of these agents: the initial choice of anti-diabetic drug has been compared in a randomized controlled trial which found "cumulative incidence of monotherapy failure at 5 years of 15% with rosiglitazone, 21% with metformin, and 34% with glyburide". Of these, rosiglitazone had more weight gain and edema. Rosiglitazone may increase risk of death from cardiovascular causes. Pioglitazone and rosiglitazone may increase the risk of fractures.

    For patients who also have heart failure, metformin may be the best drug.

    Insulin preparations Starting insulin If antidiabetic drugs fail (or stop helping), insulin therapy may be necessary -- usually in addition to oral medication therapy -- to maintain normal glucose levels.

    Typical total daily dosage of insulin is 0.6 U/kg. More complicated estimations to guide initial dosage of insulin are:

    The initial insulin regimen can be chosen based on the patient's blood glucose profile. Initially, adding nightly insulin to patients failing oral medications may be best. Nightly insulin combines better with metformin that with sulfonylureas. The initial dose of nightly insulin (measured in IU/d) should be equal to the fasting blood glucose level (measured in mmol/L). If the fasting glucose is reported in mg/dl, multiple by 0.05551 to convert to mmol/L.

    When nightly insulin is insufficient, choices include:



    Alternative Medicines Carnitine has been shown to increase insulin sensitivity and glucose storage in humans. . It is important to note that this was with a constant blood infusion, not an oral dose, and that the clinical significance of this result is unclear.

    Taurine has also shown significant improvement in insulin sensitivity and hyperlipidemia in rats.

    Neither of these have shown permanent positive effects, nor a complete restoration to pre-diabetes conditions, only improvement. Their clinical importance in humans remains unclear.

    Antihypertensive agents The goal blood pressure is 130/80 which is lower than in non-diabetic patients.

    ACE inhibitors The HOPE study suggests that diabetics should be treated with ACE inhibitors (specifically ramipril 10 mg/d) if they have one of the following : After treatment with ramipril for 5 years the number needed to treat was 50 patients to prevent one cardiovascular death. Other ACE inhibitors may not be as effective.

    Hypolipidemic agents Footnotes External links

    Diabetes mellitus type 2 (formerly called diabetes mellitus type II, non insulin-dependent diabetes (NIDDM), obesity related diabetes, or adult-onset diabetes) is a metabolism disorder that is primarily characterized by insulin resistance, relative insulin deficiency, and hyperglycemia. It is often managed by engaging in exercise and modifying one's diet. It is rapidly increasing in the developed world, and there is some evidence that this pattern will be followed in much of the rest of the world in coming years. The Centers for Disease Control and Prevention has characterized the increase as an epidemic.{{Citation | last =Gerberding | first =Julie Louise | title =Diabetes, Disabling Disease to Double by 2050 | date =2007-05-24 | year =2007 | publisher =CDC | url =http://www.cdc.gov/nccdphp/publications/aag/ddt.htm | accessdate =2007-09-14 -->

    Unlike Diabetes mellitus type 1 diabetes, there is little tendency toward ketoacidosis in Type 2 diabetes, though it is not unknown. One effect that can occur is Non Ketonic Hyperglycemic coma. Complex and multifactorial metabolic changes lead to damage and function impairment of many organ (anatomy)s, most importantly the cardiovascular system in both types. This leads to substantially increased morbidity and death in both Type 1 and Type 2 patients, but the two have quite different origins and treatments despite the similarity in complications.
    Pathophysiology Insulin resistance means that body cell (biology) do not respond appropriately when insulin is present.

    Other important contributing factors:

    This is a more complex problem than type 1, but is sometimes easier to treat, especially in the initial years when insulin is often still being produced internally. Type 2 may go unnoticed for years in a patient before diagnosis, since the symptoms are typically milder (no ketoacidosis) and can be sporadic. However, severe complications can result from unnoticed type 2 diabetes, including renal failure, blindness, wounds that fail to heal, and coronary artery disease. The onset of the disease is most common in middle age and old age.

    Diabetes mellitus type 2 is as of 2006 of unknown etiology (i.e., origin). Diabetes mellitus with a known etiology, such as secondary to other diseases, known gene defects, trauma or surgery, or the effects of drugs, is more appropriately called secondary diabetes mellitus. Examples include diabetes mellitus caused by hemochromatosis, pancreatic insufficiency, or certain types of medications (e.g. long-term steroid use).

    About 90–95% of all North American cases of diabetes are type 2Zimmet, P., Alberti, K. G. M. M., Shaw, J. Global and societal implications of thediabetes epidemic. Nature 2001, 414, 782-787., and about 20% of the population over the age of 65 has diabetes mellitus type 2. The fraction of type 2 diabetics in other parts of the world varies substantially, almost certainly for environmental and lifestyle reasons, though these are not known in detail. Diabetes affects over 150 million people worldwide with this number expected to double by 2025. There is also a strong inheritable genetics connection in type 2 diabetes: having relatives (especially first degree) with type 2 is a considerable risk factor for developing type 2 diabetes. In addition there is also a mutation to the Islet Amyloid Polypeptide gene that results in an earlier onset, more severe form of diabetesSakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y.,Nakajima, K. & Nanjo, K. Missense mutation of amylin gene (S20G) in Japanese NIDDMpatients. Diabetes 1996, 45, 1279-1281.,Seino, S. S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Diabetologia 2001, 44, (7), 906-909.. About 55 percent of type 2 are obesity —chronic obesity leads to increased insulin resistance that can develop into diabetes, most likely because adipose tissue is a (recently identified) source of chemical signals (hormones and cytokines). Other research shows that type 2 diabetes causes obesity.

    Diabetes mellitus type 2 is often associated with obesity and hypertension and elevated cholesterol (combined hyperlipidemia), and with the condition Metabolic syndrome (also known as Syndrome X, Reavan's syndrome, or CHAOS). It is also associated with acromegaly, Cushing's syndrome and a number of otherendocrinology disorders. Additional factors found to increase risk of type 2 diabetes include agingJack, L., Jr., Boseman, L. & Vinicor, F. Aging Americans and diabetes. A public health and clinical response. Geriatrics 2004, 59, 14-17., high-fat dietsLovejoy, J. C. The influence of dietary fat on insulin resistance. Curr Diab Rep 2002, 2,435-440. and a less active lifestyleHu, F. B. Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 2003, 38,103-108..

    Diagnosis The World Health Organization definition of diabetes is for a single raised glucose reading with symptoms, otherwise raised values on two occasions, of either.: or

    Screening and prevention Interest has arisen in preventing diabetes due to research on the benefits of treating patients before overt diabetes. Although the U.S. Preventive Services Task Force (USPSTF) concluded that "the evidence is insufficient to recommend for or against routinely screening asymptomatic adults for type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose" National Guidelines Clearinghouse: Complete Summary, this was a grade I recommendation when published in 2003. However, the USPSTF does recommend screening for diabetics in adults with hypertension or hyperlipidemia ( grade B recommendation).

    In 2005, an evidence report by the Agency for Healthcare Research and Quality concluded that "there is evidence that combined diet and exercise, as well as drug therapy (metformin, acarbose), may be effective at preventing progression to DM in IGT subjects".

    Accuracy of tests for early detection If a 2-hour postload glucose level of at least 11.1 mmol/L (≥ 200 mg/dL) is used as the reference standard, the fasting plasma glucose > 7.0 mmol/L (126 mg/dL) diagnoses current diabetes with:

    A random capillary blood glucose > 6.7 mmol/L (120 mg/dL) diagnoses current diabetes with:

    Glycosylated hemoglobin values that are elevated (over 5%), but not in the diabetic range (not over 7.0%) are predictive of subsequent clinical diabetes in US female health professionals. In this study, 177 of 1061 patients with glycosylated hemoglobin value less than 6% became diabetic within 5 years compared to 282 of 26281 patients with a glycosylated hemoglobin value of 6.0% or more. This equates to a glycosylated hemoglobin value of 6.0% or more having:

    Benefit of early detection Since publication of the USPSTF statement, a randomized controlled trial of prescribing acarbose to patients with "high-risk population of men and women between the ages of 40 and 70 years with a body mass index (BMI), calculated as weight in kilograms divided by the square of height in meters, between 25 and 40. They were eligible for the study if they had Impaired glucose tolerance according to the World Health Organization criteria, plus impaired fasting glucose (a fasting plasma glucose concentration of between 100 and 140 mg/dL or 5.5 and 7.8 mmol/L) found a number needed to treat of 44 (over 3.3 years) to prevent a major cardiovascular event ACP Journal Club review.

    Other studies have shown that life-style changes ACP Journal Club review and metformin ACP Journal Club review can delay the onset of diabetes.

    Treatment Diabetes mellitus type 2 is a chronic, progressive disease that has no medically proven cure. There are two main goals of treatment of the disease:
  • reduction of mortality and concomitant morbidity (from assorted diabetic complications)
  • preservation of quality of life
    • The first goal can be achieved through close glycemic control (i.e., blood glucose levels); the reduction effect in diabetic complications has been well demonstrated in several extensive clinical trials and is thus well established. The second goal is often addressed (in developed countries) by support and care from teams of diabetic health workers (physician, PA, nurse, dietitian or a certified diabetic educator). Endocrinologists, family practitioners, and general internists are the types of physicians most likely to treat people with diabetes. Knowledgeable patient participation is vital and so patient education is a crucial aspect of this effort.

    Type 2 is initially treated by adjustment in diet and exercise, and by weight loss, especially in obese patients. The amount of weight loss which improves the clinical picture is sometimes modest (2-5 kg or 4.4-11 lb); this is almost certainly due to currently poorly understood aspects of fat tissue chemical signaling (especially in visceral fat tissue in and around abdominal organs). In many cases, such initial efforts can substantially restore insulin sensitivity.

    Treatment goals For most patients, clinical practice guidelines recommend a goal Glycosylated hemoglobin of 6.0% to 7.0%Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK, et al. Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1c Targets. A Guidance Statement from the American College of Physicians. Ann Intern Med. 2007 Sep 18;147(6):417-422. Full text.

    In older patients, clinical practice guidelines by the American Geriatrics Society states "for frail older adults, persons with life expectancy of less than 5 years, and others in whom the risks of intensive glycemic control appear to outweigh the benefits, a less stringent target such as 8% is appropriate".

    Self monitoring of blood glucose It is unclear if self-monitoring of blood glucose improves outcomes among "reasonably well controlled non-insulin treated patients with type 2 diabetes".

    Dietary management Modifying the diet is known to help control glucose intake, and in response, blood glucose levels.

    One 2007 study will report that in a Paleolithic diet, all 14 patients returned blood glucose levels to normal after the trial period of 12 weeks, and improved glucose tolerance (26% less blood glucose rise following a carbohydrate intake compared to 7% reduction for control group on a Mediterranean diet). This was the first Paleolithic diet study, and suggested that "it may be more efficient to avoid some of our modern foods than to count calories or carbohydrate".

    Other evidence for modified diets treating and being beneficial include:

    Exercise In September 2007, a joint randomized controlled trial by the University of Calgary and the University of Ottawa found that "Either aerobic or resistance training alone improves glycemic control in type 2 diabetes, but the improvements are greatest with combined aerobic and resistance training than either alone." Non-technical summary{{cite web ] by 0.5 percentage point.

    Antidiabetic drugs The most important drug now used in Type 2 Diabetes is the Biguanide metformin which works primarily by reducing liver release of blood glucose from glycogen stores as well as some increase in uptake of glucose by the body's tissues. Both historically and currently commonly used are the Sulfonylurea group, of which several members (including glibenclamide and gliclazide) are widely used; these increase glucose stimulated secretagogue by the pancreas.

    Newer drug classes include:

    Selecting an antidiabetic drug Oral drugs A systematic review of randomized controlled trials found that metformin and second-generation sulfonylureas are the preferred choices for most.Bolen S et al. Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus. Ann Intern Med 2007;147:6 Failure of response after a time is not unknown with most of these agents: the initial choice of anti-diabetic drug has been compared in a randomized controlled trial which found "cumulative incidence of monotherapy failure at 5 years of 15% with rosiglitazone, 21% with metformin, and 34% with glyburide". Of these, rosiglitazone had more weight gain and edema. Rosiglitazone may increase risk of death from cardiovascular causes. Pioglitazone and rosiglitazone may increase the risk of fractures.

    For patients who also have heart failure, metformin may be the best drug.

    Insulin preparations Starting insulin If antidiabetic drugs fail (or stop helping), insulin therapy may be necessary -- usually in addition to oral medication therapy -- to maintain normal glucose levels.

    Typical total daily dosage of insulin is 0.6 U/kg. More complicated estimations to guide initial dosage of insulin are:

    The initial insulin regimen can be chosen based on the patient's blood glucose profile. Initially, adding nightly insulin to patients failing oral medications may be best. Nightly insulin combines better with metformin that with sulfonylureas. The initial dose of nightly insulin (measured in IU/d) should be equal to the fasting blood glucose level (measured in mmol/L). If the fasting glucose is reported in mg/dl, multiple by 0.05551 to convert to mmol/L.

    When nightly insulin is insufficient, choices include:



    Alternative Medicines Carnitine has been shown to increase insulin sensitivity and glucose storage in humans. . It is important to note that this was with a constant blood infusion, not an oral dose, and that the clinical significance of this result is unclear.

    Taurine has also shown significant improvement in insulin sensitivity and hyperlipidemia in rats.

    Neither of these have shown permanent positive effects, nor a complete restoration to pre-diabetes conditions, only improvement. Their clinical importance in humans remains unclear.

    Antihypertensive agents The goal blood pressure is 130/80 which is lower than in non-diabetic patients.

    ACE inhibitors The HOPE study suggests that diabetics should be treated with ACE inhibitors (specifically ramipril 10 mg/d) if they have one of the following : After treatment with ramipril for 5 years the number needed to treat was 50 patients to prevent one cardiovascular death. Other ACE inhibitors may not be as effective.

    Hypolipidemic agents Footnotes External links



    Diabetes mellitus type 2 - Wikipedia, the free encyclopedia
    Diabetes mellitus type 2 or Type 2 Diabetes (formerly called non - insulin-dependent diabetes mellitus (NIDDM), or adult-onset diabetes) is a metabolic disorder that is primarily ...

    Type 2 Diabetes
    Diabetes Mellitus Type 2, also known as type 2 diabetes, is a globally common metabolic disorder affecting over two million people in the UK alone.

    Diabetes Guidelines Europe Type 2
    TYPE 2 DIABETES - ACKNOWLEDGEMENTS ( Contents list) ( Index) ( Top of page) ACKNOWLEDGEMENTS. The production of these Guidelines was made possible by the financial support of a ...

    Type 2 Diabetes: Conditions, Treatments, Resources - American Diabetes ...
    Information on type 2 diabetes: diabetes conditions, diabetes treatment, resources from the American Diabetes Association.

    Diabetes overview
    In Type 2 diabetes, however, symptoms can appear close to the time of actual diagnosis because the disease may go undetected for longer.

    Prevention of Type 2 Diabetes Mellitus
    See also: Screening for diabetes, insulin resistance, managing impaired glucose tolerance in primary care, gestational diabetes.

    MedlinePlus Medical Encyclopedia: Type 2 diabetes
    Alternative Names Return to top. Noninsulin-dependent diabetes; Diabetes - type 2. Definition Return to top. Type 2 diabetes is a life-long disease marked by high levels of ...

    Type 2 Diabetes Mellitus Quiz and answers
    NPC materials may be downloaded / copied freely by people employed by the NHS in England for purposes that support NHS activities in England. Any person not employed by the NHS, or ...

    Evaluation of Type 2 Diabetes Mellitus Screening against the NSC ...
    Evaluation of Type 2 Diabetes Mellitus Screening against the NSC Handbook Criteria

    PCEL - SNOMED CT Directory: Diabetes mellitus type 2
    Diabetes mellitus due to insulin receptor antibodies (0) NIDDM in nonobese (0) Pre-existing diabetes mellitus, non-insulin-dependent (0) Insulin-treated non-insulin-dependent ...

     

    Diabetes Mellitus Type 2



     
    Copyright © 2008 Hintcenter.com - All rights reserved.
    Home | Terms of Use | Privacy Policy
    All Trademarks belong to their repective owners. Many aspects of this page are used under
    commercial commons license from Yahoo!